
浏览全部资源
扫码关注微信
400037 重庆,陆军军医大学(第三军医大学)第二附属医院病理科
[郭乔楠,E-mail:qiaonan85@263.net GUO Qiaonan, E-mail:qiaonan85@263.net
收稿:2017-11-03,
修回:2017-12-07,
纸质出版:2018-04-15
移动端阅览
彭动斌, 唐雪峰, 高自然, 等. 下调Notch3表达对骨肉瘤细胞生物学特性的影响[J]. 第三军医大学学报, 2018,40(7):551-555.
Dongbin PENG, Xuefeng TANG, Ziran GAO, et al. Effect of down-regulating Notch3 expression on biological characteristics of osteosarcoma cells[J]. Journal of Third Military Medical University, 2018, 40(7): 551-555.
彭动斌, 唐雪峰, 高自然, 等. 下调Notch3表达对骨肉瘤细胞生物学特性的影响[J]. 第三军医大学学报, 2018,40(7):551-555. DOI: 10.16016/j.1000-5404.201711019.
Dongbin PENG, Xuefeng TANG, Ziran GAO, et al. Effect of down-regulating Notch3 expression on biological characteristics of osteosarcoma cells[J]. Journal of Third Military Medical University, 2018, 40(7): 551-555. DOI: 10.16016/j.1000-5404.201711019.
目的
2
观察Notch3在骨肉瘤细胞中的表达及下调Notch3表达后对骨肉瘤细胞增殖、凋亡及侵袭迁移的影响,探讨Notch3在骨肉瘤细胞生物学功能中的作用。
方法
2
体外培养人骨肉瘤细胞MG63、Saos2、U2OS,采用Real-time PCR和Western blot检测3种骨肉瘤细胞系中Notch3的mRNA和蛋白表达水平;利用siRNA敲低Notch3在骨肉瘤U2OS细胞中的表达,并将细胞分为siNotch3组和阴性对照组,检测下调Notch3的表达后骨肉瘤细胞增殖、凋亡及侵袭、迁移等生物学特性的变化。
结果
2
Notch3在骨肉瘤细胞MG63、Saos2、U2OS中均呈阳性表达,并且在低级别骨肉瘤细胞系MG63中的表达明显低于高级别细胞系Saos2和U2OS(
P
<
0.05),下调Notch3的U2OS细胞(siNotch3组)增殖、侵袭、迁移能力较阴性对照组减弱,凋亡率增加,差异均有统计学意义(
P
<
0.05)。
结论
2
在骨肉瘤细胞U2OS中下调Notch3的表达可明显抑制细胞的增殖、侵袭、迁移能力,促进凋亡。Notch3可能是Notch通路在骨肉瘤中的关键受体之一,并参与了骨肉瘤的发生、发展。
Objective
2
To explore the expression of Notch3 in human of osteosarcoma cells and determine the effect of its down-regulation on the proliferation
apoptosis
invasion and migration
and to investigate its role in the biological function of the cells.
Methods
2
Real-time PCR and Western blotting were used to examine the expression of Notch3 at mRNA and protein levels in osteosarcoma cell lines. siRNA was used to knockdown the expression of Notch3 in U2OS cells. Then the proliferation
apoptosis and metastasis of the cells after transfection were detected for the effects of Notch3 down-regulation.
Results
2
Notch3 was highly expressed in human osteosarcoma cell lines MG63
Saos2 and U2OS
but its level was significantly lower in MG63 cells derived from low-grade osteosarcoma than those in Saos2 and U2OS cells derived from high-grade osteosarcoma (
P
<
0.05). When compared with untreated cells (Control)
down-regulation of Notch3 in U2OS cells markedly repressed cell proliferation
decreased invasion and migration (
P
<
0.05). but enhanced apoptosis (
P
<
0.05).
Conclusion
2
Down-regulation of Notch3 reduces the proliferation
invasion
migration
but increases the apoptosis in osteosarcoma cells. Notch3 may be a key receptor of Notch pathway involving in the occurrence and development of osteosarcoma.
MIRABELLO L, TROISI R J, SAVAGE S A.Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program[J]. Cancer, 2009, 115(7): 1531-1543. DOI: 10.1002/cncr.24121.
SICLARI V A, QIN L.Targeting the osteosarcoma cancer stem cell[J]. J Orthop Surg Res, 2010, 5:78. DOI:10.1186/1749-799X-5-78.
LONGHI A, ERRANI C, DE PAOLIS M, et al . Primary bone osteosarcoma in the pediatric age: state of the art[J ] . Cancer Treat Rev, 2006, 32(6): 423-436. DOI:10.1016/j.ctrv.2006.05.005.
RANGANATHAN P, WEAVER K L, CAPOBIANCO A J.Notch signalling in solid tumours: a little bit of everything but not all the time[J]. Nat Rev Cancer, 2011, 11(5): 338-351. DOI: 10.1038/nrc3035.
LI C J, LIU X Z, ZHANG L, et al . Advances in bone-targeted drug delivery systems for neoadjuvant chemotherapy for osteosarcoma[J ] . Orthop Surg, 2016, 8(2): 105-110.DOI: 10.1111/os.12238.
YU L, FAN Z, FANG S, et al .Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling[J ] . Oncotarget, 2016, 7(22): 33055-33068.DOI:10.18632/oncotarget.8849.
BRZOZOWA-ZASADA M, PIECUCH A, DITTFELD A, et al . Notch signalling pathway as an oncogenic factor involved in cancer development[J ] . Contemp Oncol (Pozn), 2016, 20(4):267-272.DOI: 10.5114/wo.2016.61845.
BRZOZOWA M, MIELAŃCZYK L, MICHALSKI M, et al .Role of Notch signaling pathway in gastric cancer pathogenesis[J ] . Contemp Oncol (Pozn), 2013, 17(1):1-5. DOI:10.5114/wo.2013.33765.
YUAN X, ZHANG M, WU H, et al . Expression of Notch1 correlates with breast cancer progression and prognosis[J ] . PLoS ONE, 2015, 10(6):e0131689. DOI:10.1371/journal. pone.0131689.
ZHOU L, ZHANG N, SONG W, et al . The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma[J ] . PLoS ONE, 2013, 8(2):e57382. DOI: 10.1371/journal.pone.0057382.
OSANYINGBEMI-OBIDI J, DOBROMILSKAYA I, ILLEI P B, et al . Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo [J ] . Mol Cancer Res, 2011, 9(12):1746-1754. DOI: 10.1158/1541-7786.MCR-11-0286..
ENGIN F, BERTIN T, MA O, et al . Notch signaling contributes to the pathogenesis of human osteosarcomas[J ] . Hum Mol Genet, 2009, 18(8):1464-1470. DOI: 10.1093/hmg/ddp057.
MCMANUS M M, WEISS K R, HUGHES D P. Understanding the role of Notch in osteosarcoma[J]. Adv Exp Med Biol, 2014, 804:67-92. DOI: 10.1007/978-3-319-04843-7_4.
LI C, GUO D, TANG B, et al . Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression[J ] . Neoplasma, 2016, 63(5):734-742. DOI: 10.4149/neo_2016_510.
WANG L, JIN F, QIN A, et al .Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family[J ] . Mol Cancer, 2014, 13:139. DOI: 10.1186/1476-4598-13-139.
ZHANG H, LIU L, LIU C, et al . Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma[J ] . Oncotarget, 2017, 8(21):34362-34373. DOI: 10.18632/oncotarget.16156.
YAO J, QIAN C.Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway[J]. Med Oncol, 2010, 27(3):1017-1022.DOI: 10.1007/s12032-009-9326-5.
LIU Z, YUN R, YU X, et al . Overexpression of Notch3 and pS6 is associated with poor prognosis in human ovarian epithelial cancer[J ] . Mediators Inflamm, 2016, 2016:5953498. DOI: 10.1155/2016/5953498.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621